Literature DB >> 32441666

Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.

Xiurong Ding1, Yanhua Yu1, Bichao Lu2, Jianbo Huo2, Ming Chen1, Yanfang Kang1, Jinli Lou1, Zhizhong Liu2.   

Abstract

Objectives As people across the world suffer from coronavirus disease 2019 (COVID-19), further studies are needed to facilitate evaluating the severity and prognosis of COVID-19 patients. In the study, we aimed to dissect the dynamic profile and clinical implications of hematological findings in hospitalized patients with COVID-19. Methods We retrospectively analyzed the hematological findings of 72 patients with COVID-19 admitted from January 21 to February 17, 2020. The final date of follow-up was March 20, 2020. Dynamic profile of vital hematological parameters in severe and non-severe patients was presented at different time points (day 1, 5, 7, 9, 11, 13, 15 after admission), and the correlation of hematological parameters with hospitalization time was indicated. Results Of 72 patients with COVID-19, lymphopenia and leukopenia occurred in 39 (54.2%) and 20 (27.8%) patients with COVID-19, respectively. Fifteen (20.8%) patients were defined as severe cases and 57 (79.2%) were non-severe cases. Compared to non-severe patients, leukocyte count, neutrophil count and neutrophil-to-lymphocyte ratio (NLR) were significantly higher, whereas lymphocyte count was declined in severe patients at each time point. A growing trend in platelet count was found in non-severe patients over the follow-up period. In addition, a positive correlation of NLR with hospitalization time was detected from day 5 after admission. Conclusions Dynamic changes in vital hematological parameters from severe and non-severe patients had been characterized in the course of hospitalization. During hospitalization, NLR was found to have certain relevance to the hospitalization days and a role in forecasting disease prognosis for patients with COVID-19.

Entities:  

Keywords:  coronavirus disease 2019; hematological parameters; hospitalization time; neutrophil-to-lymphocyte ratio; severe acute respiratory syndrome coronavirus 2

Mesh:

Year:  2020        PMID: 32441666     DOI: 10.1515/cclm-2020-0411

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  26 in total

1.  Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.

Authors:  Jayalakshmi Balasubramanian; Febe Renjitha Suman; Immanuel Ratan Stephen; Sri Gayathri Shanmugam; Rajkumar Mani; Bhargavi Mathan; Lakshmi P
Journal:  Cureus       Date:  2021-11-15

2.  Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios.

Authors:  Eduardo Avila; Alessandro Kahmann; Clarice Alho; Marcio Dorn
Journal:  PeerJ       Date:  2020-06-29       Impact factor: 2.984

3.  Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective.

Authors:  Mukta Pujani; Sujata Raychaudhuri; Nikhil Verma; Harnam Kaur; Shivani Agarwal; Mitasha Singh; Manjula Jain; R K Chandoke; Kanika Singh; Dipti Sidam; Varsha Chauhan; Aparna Singh; Khushbu Katarya
Journal:  Am J Blood Res       Date:  2021-04-15

4.  β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.

Authors:  Niraj Kumar Jha; Charu Sharma; Hebaallah Mamdouh Hashiesh; Seenipandi Arunachalam; Mf Nagoor Meeran; Hayate Javed; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

5.  Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients.

Authors:  Arife Erdogan; Fatma Ezgi Can; Hayriye Gönüllü
Journal:  J Med Virol       Date:  2021-05-28       Impact factor: 20.693

6.  An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.

Authors:  Mukta Pujani; Sujata Raychaudhuri; Mitasha Singh; Harnam Kaur; Shivani Agarwal; Manjula Jain; R K Chandoke; Kanika Singh; Dipti Sidam; Varsha Chauhan
Journal:  Am J Blood Res       Date:  2021-12-15

7.  The natural course of COVID-19 patients without clinical intervention.

Authors:  Daxian Wu; Qunfang Rao; Wenfeng Zhang
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

8.  Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.

Authors:  Xue Wang; Xincheng Li; Yu Shang; Junwei Wang; Xiaona Zhang; Dongju Su; Shuai Zhao; Qin Wang; Lei Liu; Yupeng Li; Hong Chen
Journal:  Epidemiol Infect       Date:  2020-09-09       Impact factor: 2.451

9.  Role of Hematological and Immunological Parameters in COVID-19 Patients.

Authors:  Avanindra Kumar; Shipra Sepolia; R H Shilpa; Gilda Rezayani; Soni Kumari; Shivangi Gupta
Journal:  J Pharm Bioallied Sci       Date:  2021-05-26

Review 10.  Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.